Rajesh P Shah, MD
Interventional Radiology · Berkeley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 8
Offices
8 locations · UCSF Medical Group Business Services · Alameda Health System · University of California San Francisco
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Shah’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence A108617 · Current
Licensed to practise in California · since 2009 · expires 2027-02-28 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$106,787
Medicare paid this office $106,787 for 795 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ct scan of abdomen and pelvis with contrast | 87 | $5,872 | $67 |
| Insertion of central venous tube with port (5 years or older) | 18 | $5,218 | $290 |
| Mri scan of pelvis before and after contrast | 60 | $4,656 | $76 |
| Mri scan of abdomen before and after contrast | 50 | $4,192 | $81 |
| Drainage of fluid from abdominal cavity using imaging guidance | 33 | $4,149 | $86 |
See all 31 services
| Ct scan of abdomen and pelvis with contrast | 87 | $5,872 | $67 |
| Insertion of central venous tube with port (5 years or older) | 18 | $5,218 | $290 |
| Mri scan of pelvis before and after contrast | 60 | $4,656 | $76 |
| Mri scan of abdomen before and after contrast | 50 | $4,192 | $81 |
| Drainage of fluid from abdominal cavity using imaging guidance | 33 | $4,149 | $86 |
| Insertion of tunneled central venous tube for infusion (5 years or older) | 16 | $3,393 | $212 |
| Review by radiologist of ct guidance for needle placement | 36 | $2,181 | $61 |
| Aspiration of fluid from chest cavity using imaging guidance | 20 | $2,143 | $93 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 26 | $2,141 | $76 |
| Drainage of fluid collection of abdominal cavity by tube using imaging guidance | 12 | $2,063 | $147 |
| Insertion of stomach tube using fluoroscopic guidance with contrast | 11 | $1,926 | $175 |
| Ct scan of chest with contrast | 40 | $1,721 | $42 |
| Replacement of kidney drainage tube using imaging guidance with review by radiologist | 17 | $1,626 | $96 |
| Ct scan of blood vessels of chest with contrast | 24 | $1,441 | $58 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 133 | $1,436 | $10 |
| Ct scan head or brain without contrast | 45 | $1,419 | $32 |
| Replacement of liver duct drainage tube using imaging guidance with review by radiologist | 12 | $1,408 | $108 |
| Ct scan of chest without contrast | 34 | $1,363 | $40 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 12 | $1,144 | $95 |
| Ct scan of abdomen and pelvis without contrast | 19 | $1,119 | $59 |
| Ct scan of abdomen and pelvis before and after contrast | 12 | $1,081 | $83 |
| Mri scan of abdomen without contrast | 17 | $946 | $56 |
| Exchange of abdominal cavity drainage tube using imaging guidance | 13 | $808 | $50 |
| Fluoroscopic guidance for insertion or removal of central vein access device | 50 | $752 | $15 |
| Review by radiologist of image for replacement of stomach or large bowel tube | 13 | $625 | $33 |
| Ultrasonic guidance for blood vessel access | 49 | $592 | $12 |
| Injection of contrast through abdominal cavity tube for x-ray study | 14 | $476 | $26 |
| Ct scan of upper spine without contrast | 12 | $455 | $35 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 15 | $388 | $26 |
| Review by radiologist of abscess or sinus cavity study | 14 | $384 | $21 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $273 | $16 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
Who their Medicare patients are
795 Original Medicare patients in 2024. Average age 73 · Under 65 12% · 85 and older 13% · Women 48% · Also on Medicaid 41% · Health risk score 2.47. Above the middle of the specialty; the typical interventional radiology clinician is at 2.27.
Conditions among them: High blood pressure 75% · Chronic kidney disease 39% · Diabetes 38% · Coronary heart disease 35% · Cancer 30% · Heart failure 28% · Atrial fibrillation 27% · Depression 27% · COPD 22% · Dementia 14% · Stroke 14%.
The office billed $1,907,936, Medicare allowed $139,362 and paid $106,787; for 1,893 services of 182 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 795 | 1,893 | 73 | 2.47 | $1,907,936 | $106,787 |
| 2023 | 645 | 969 | 74 | 1.88 | $264,656 | $59,804 |
| 2018 | 13 | 33 | 68 | 2.60 | $25,273 | $2,289 |
| 2016 | 23 | 43 | 72 | 3.08 | $53,159 | $5,655 |
| 2015 | 73 | 253 | 68 | 2.80 | $384,475 | $30,831 |
| 2014 | 81 | 232 | 68 | 2.57 | $321,444 | $24,192 |
| 2013 | 18 | 48 | 67 | 1.67 | $108,429 | $6,356 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Mri scan of abdomen before and after contrast | 56 | $5,319 | $93 |
| Mri scan of pelvis before and after contrast | 50 | $4,760 | $95 |
| Ct scan of abdomen and pelvis with contrast | 53 | $4,007 | $73 |
| Drainage of fluid from abdominal cavity using imaging guidance | 22 | $2,542 | $94 |
| Review by radiologist of ct guidance for needle placement | 31 | $2,089 | $63 |
| Ct scan of blood vessels of chest with contrast | 28 | $1,963 | $70 |
| Ct scan of abdomen and pelvis without contrast | 23 | $1,853 | $71 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 20 | $1,852 | $93 |
| Ct scan of chest without contrast | 39 | $1,638 | $42 |
| Mri scan of abdomen without contrast | 26 | $1,628 | $63 |
| Needle biopsy of kidney | 14 | $1,595 | $114 |
| Aspiration of fluid from chest cavity using imaging guidance | 16 | $1,550 | $97 |
| Ct scan of chest with contrast | 26 | $1,272 | $45 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 60 | $693 | $11 |
| Ct scan of abdomen without contrast | 12 | $674 | $52 |
| Ct scan head or brain without contrast | 18 | $649 | $36 |
| Ultrasonic guidance for needle placement | 17 | $465 | $27 |
| Ct guidance for insertion of radiation therapy fields | 11 | $461 | $42 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 13 | $384 | $30 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 19 | $360 | $19 |
| X-ray of chest, 1 view | 29 | $240 | $8 |
2015: 4 services
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 11 | $1,941 | $162 |
| Review by radiologist of abdominal artery image | 13 | $896 | $50 |
| Review by radiologist of ct guidance for needle placement | 12 | $621 | $52 |
| Review by radiologist of additional artery image | 12 | $547 | $16 |
2014: 2 services
| Review by radiologist of ct guidance for needle placement | 17 | $851 | $50 |
| Review by radiologist of image for replacement of stomach or large bowel tube | 13 | $441 | $31 |
Medicaid work
$997 in 2024
Medicaid paid $997 for 16 billed services this clinician did in 2024, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 16 | $997 |
| 2024 | 16 | 1 | 16 | $997 |
| 2023 | 12 | 1 | 12 | $589 |
See the largest Medicaid services in earlier years
2023
| CT ABDOMEN & PELVIS W/CONTRAST MATERIAL | 12 | $589 |
Money from drug and device companies
$6,732 in 2025
| 2025 | 5 | 21 | $5,300 | $6,732 |
| 2024 | 3 | 4 | None | $167 |
| 2021 | 1 | 1 | $1,250 | $1,250 |
| 2020 | 2 | 6 | $6,276 | $6,276 |
| 2019 | 1 | 1 | $600 | $600 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Esprit | $3,600 | 3 payments
|
| Siemens Medical Solutions USA | None | $1,700 | 1 payment
|
| Histosonics | None | $885 | 2 payments
|
| Boston Scientific | Therasphere Administration Set | $519 | 12 payments
|
| Terumo Medical | Azur Cx Detachable | $28 | 1 payment
|
See all 19 published payments
| Boston Scientific | Meals · 2025-10-25 | Obsidio | $35 |
| Boston Scientific | Meals · 2025-10-03 | Obsidio | $40 |
| Siemens Medical Solutions USA | Consulting · 2025-09-24 | None | $1,700 |
| Boston Scientific | Meals · 2025-09-10 | Embold Fibered | $32 |
| Boston Scientific | Meals · 2025-08-15 | Obsidio | $12 |
| Terumo Medical | Meals · 2025-08-07 | Azur Cx Detachable | $28 |
| Boston Scientific | Meals · 2025-08-01 | Obsidio | $38 |
| Boston Scientific | Meals · 2025-06-24 | Obsidio | $29 |
| Abbott Laboratories | Consulting · 2025-05-27 | Esprit | $1,100 |
| Abbott Laboratories | Consulting · 2025-05-06 | Esprit | $2,000 |
| Histosonics | Travel · 2025-04-27 | None | $128 |
| Boston Scientific | Meals · 2025-03-29 | Intracept | $96 |
| Boston Scientific | Meals · 2025-03-28 | Embold Fibered | $26 |
| Boston Scientific | Meals · 2025-03-19 | Therasphere Administration Set | $148 |
| Boston Scientific | Meals · 2025-03-18 | Embold Fibered | $29 |
| Histosonics | Travel · 2025-03-17 | None | $757 |
| Boston Scientific | Meals · 2025-03-04 | Embold Fibered | $23 |
| Boston Scientific | Meals · 2025-02-16 | Therasphere Administration Set | $10 |
| Abbott Laboratories | Consulting · 2025-02-13 | Esprit | $500 |
See earlier years (2024, 2021, 2020, 2019)
2024: $167
| Abbott Laboratories | Aveir | $71 | 1 payment
|
| Terumo Medical | Glidesheath Slender | $50 | 1 payment
|
| Boston Scientific | Embold Fibered | $46 | 2 payments
|
2021: $1,250
| Intuitive Surgical | Da Vinci Surgical System | $1,250 | 1 payment
|
2020: $6,276
| Genentech | None | $5,076 | 3 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $1,200 | 3 payments
|
2019: $600
| Intuitive Surgical | Da Vinci Surgical System | $600 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Merit Medical Systems Inc · Hepasphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer · 2020 | Their institution | $12,778 |
| Merit Medical Systems Inc · Hepasphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer · 2021 | Their institution | $3,786 |
Professional record
- NPI
- 1982867321
- Licence
- CA A108617California A108617: Current · expires 2027-02-28
- Group
- UCSF Medical Group Business Services · Alameda Health System · University of California San Francisco
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2085R0204X (2085R0204X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2008-07-07
- NPI last updated
- 2024-04-07
- NPI record certified
- 2024-04-07
This is when the NPI record was last certified, not a medical board exam.